Spero Therapeutics Announces Special Protocol Assessment Agreement with FDA for Phase 3 ...

Phase3PIVOT-POtrialisexpectedtobeginwithFirstPatient,FirstVisitin4Q2023

Related Keywords

Japan ,United States ,Massachusetts ,Cambridge ,Cambridgeshire ,United Kingdom ,Ted Jenkins ,Kamal Hamed ,Lora Grassilli ,Drug Administration ,Tebipenem Hbr Research ,Exchange Commission ,Health Media Relations Zeno Group ,Human Services ,Meiji Seika Pharma Co ,Administration For Strategic Preparedness ,Development Authority ,Biomedical Advanced Research ,Department Of Health ,Spero Therapeutics Inc ,Nasdaq ,Special Protocol Assessment ,Chief Medical Officer ,Meiji Seika Pharma ,Qualified Infectious Disease Product ,Fast Track ,Strategic Preparedness ,Relations Contact ,Investor Relations ,Health Media Relations Zeno ,Region ,